Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Humana

US stocks today: S&P 500, Nasdaq end lower as inflation, Iran tensions weigh

US stocks closed lower as hotter-than-expected inflation and escalating US-Iran tensions weighed on sentiment. The S&P 500 and Nasdaq retreated from record highs, led by tech weakness, while Dow held steady. Rising oil prices and fears of prolonged inflation reduced hopes of Fed rate cuts and lifted rate-hike bets.

The Economic Times

AdaptHealth Conference: Kaiser Deal Drives Growth, Labor Costs Dent EBITDA

AdaptHealth (NASDAQ:AHCO) told investors at a Bank of America event that first-quarter results reflected broad organic growth across its business lines, but also higher-than-expected labor costs tied to a major capitated contract transition. Bank of America analyst Joanna Gajuk opened the discussio

MarketBeat

Humana Surges Above 50-Day MA. Should You Buy HUM Stock on CMS Rate Changes Here?

Humana shares rally as CMS finalized 2027 Medicare Advantage payments rate at 2.48%. Valuation and options pricing warrant owning HUM shares in 2026.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

What You Need To Know Ahead of Humana's Earnings Release

Humana is scheduled to release its first-quarter results later this month, with analysts projecting double-digit earnings drop.

Barchart

U.S. Health Insurers Rally As Medicare Advantage Payments Jump Beyond Expectations

The unexpected CMS rate hike eases pressure on insurer margins and signals potential stability in Medicare Advantage coverage for tens of millions of beneficiaries.

International Business Times

1.2 Million Dropped: The Major Insurers Exiting Medicare Advantage Plans This Year

Imagine opening your mail and discovering your health plan is disappearing. That’s exactly what’s happening to more than 1.2 million seniors this year as insurers...

Saving Advice

Is Humana Stock Underperforming the S&P 500?

Humana has notably underperformed the S&P 500 over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Some Blue Cross and Humana Plans Update Provider Networks in Spring — Here’s How It Affects Patients

Spring is bringing more than warm weather this year — it’s bringing fresh changes to several Blue Cross and Humana provider networks, and many patients...

Saving Advice

Should You Buy the Dip in These 2 Dividend Stocks?

Tighter Medicare Advantage payment rates are testing two established health insurers, with CVS Health offering a safer dividend entry at 28% upside and 3% yield while Humana's 36% year-over-year decline creates a riskier but potentially stronger bounce-back opportunity if profitability stabilizes faster than the market expects.

Barchart

These Are the 3 Top Oversold S&P 500 Stocks. Should You Buy the Dip?

Abbott, Roper, and Humana are three blue-chip oversold stocks with significant upside potential for shareholders in January 2026.

Barchart

6 Medicare Providers Dropping Out of Networks

For millions of seniors, the promise of Medicare Advantage (Part C) was simple: lower premiums in exchange for staying within a network. In 2026, that...

Saving Advice

We must not let AI ‘pull the doctor out of the visit’ for low-income patients

Generative AI is being pushed into healthcare – and diagnostic risks may deepen the class divide

The Guardian - US

What to Expect From Humana’s Next Quarterly Earnings Report

Humana has scheduled to release its fiscal fourth-quarter earnings next month, and analysts project a significant loss.

Barchart

Medicare “Carrier Contraction”: Why UnitedHealthcare and Humana Just Exited 400+ Counties

If you’ve ever told yourself Medicare Advantage “doesn’t really change,” 2026 is here to challenge that idea. In a lot of places, plan choices are...

Saving Advice

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

AI doctors will be good at science but bad at business, and big talk with little action means even higher drugs prices: 10 healthcare predictions for 2026 from top investors

We hope 2026 is calmer after tariffs, public health chaos, and the cancellation of billions of research funding and health coverage support for millions.

Barchart

Humana Stock Is Nearly 20% Off Its YTD Highs. Can Mark Cuban Change That?

Mark Cuban is allegedly looking to partner with Humana on pharmacy offerings.

Barchart

How Is Humana Stock Performance Compared to Other Healthcare Services Stocks?

Humana stock has underperformed compared to the healthcare services group, but analysts remain fairly bullish about its prospects.

Barchart

As Trump Calls Insurers ‘BIG,’ ‘BAD,’ and ‘Money Sucking,’ How Should You Play UnitedHealth Stock?

UnitedHealth shares dipped earlier this week as Trump’s populist healthcare remarks rattled insurers, but fundamentals and long-term guidance may tell a more resilient story.

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Humana CEO is betting on culture change and AI to fuel a turnaround

Also: All the news and watercooler chat from Fortune.

Fortune

From the Peace Corps to the boardroom: Humana CEO Jim Rechtin on listening and leading

In a conversation with Fortune, Rechtin said the health-insurance giant that primarily serves seniors is "not where we want to be."

The Guardian - UK

Continental thrift: five of the best cities in Europe for vintage shopping

From flea markets in Berlin to thrift stores in Athens, a vintage shopping veteran picks her favourite places to shop for preloved bargains and unique souvenirs

Benzinga

Humana Q3 Premium Growth Offsets Membership Drop, Stock Tumbles

Humana Inc. (NYSE:HUM) released its third-quarter earnings report on Wednesday, with adjusted earnings of $3.24, exceeding the consensus estimate of $2.82.

International Business Times UK

Humana Medicare Advantage Crisis: Ratings Meltdown Puts Senior Healthcare at Risk

Humana faces a Medicare Advantage crisis as downgraded star ratings threaten senior insurance coverage and reshape the 2026 healthcare market.

Benzinga

Humana Loses Court Battle Over Medicare Advantage Ratings, Billions In Payments At Risk

Humana Inc. (NYSE:HUM) lost a legal battle challenging cuts to its Medicare Advantage bonus payments, raising concerns over billions in potential revenue.

Kiplinger

Major Insurers Scale Back Medicare Advantage and Part D Plans for 2026

Beneficiaries enrolled in Medicare Advantage and Part D prescription drug plans might be losing their plan as UnitedHealthcare, Humana, and Aetna (CVS Health) scale back offerings for 2026.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.